Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bing Li
Bing Li, Bothell, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080290066 | Method of Fabricating Polymer Modulators With Etch Stop Clads - A process that comprises dry etching a trench into a side clad polymer layer using an underlying passive polymer layer as an etch stop, and then back filling the trench with an electro-optic polymer. | 11-27-2008 |
| 20100040322 | INTEGRATED ELECTRO-OPTIC DEVICE AND METHOD OF MAKING - An electro-optic polymer semiconductor integrated circuit includes one or more doped regions configured to drive one or more electrodes, and the electrodes are configured to drive a juxtaposed electro-optic core. The assembly may include a planarization layer disposed at least partially coplanar with the electrodes. The circuit may include an integrated multiplexer, driver configured to receive a signal from the multiplexer, at least one high speed electrode configured to be driven by the driver and modulate light energy passed through a hyperpolarizable poled chromophore regions disposed near the high speed electrode. The circuit may include a calibration storage circuit. The circuit may include, during fabrication, structures to provide voltage to a buried electrode and a shield to prevent damage from the poling field. | 02-18-2010 |
| 20100172619 | Single Mode Photonic Circuit Architecture and a New Optical Splitter Design Based on Parallel Waveguide Mode Conversion - The new single mode circuit (SMC) architecture is invented for photonic integrated circuits (PIC). This architecture allows using multimode waveguides or structures to construct a single mode operated PIC. The multimode sections used in such SMC based PIC possess strong lateral confinement so that the PIC can have high circuit density and high optical performance at the same time. A parallel mode converter structure is also invented here. Based on this parallel mode converter, a low loss optical splitter can be constructed for high index contrast waveguide system. | 07-08-2010 |
| 20110091148 | Circuit architecture for electro-optic modulation based on free carrier dispersion effect and the waveguide capacitor structures for such modulator circuitry using CMOS or Bi-CMOS process - New circuit architecture for electro-optic modulator based on free-carrier dispersion effect is invented, in which the waveguide capacitor of the modulator is embed in the circuits and physically layout together with transistors, the switching of the modulator occurs in transistors, and as the result, the electro-optical modulation occurs in the waveguide capacitor. The invented modulator is not one physical device, it is actually a circuit. Several circuit design techniques are imported, leading to several new modulator circuits that have very high operation speed and very small power consumption. Several new waveguide capacitor structures are also invented that allow high efficient modulator circuits to be built. | 04-21-2011 |
| 20120008897 | Single Mode Photonic Circuit Architecture and a New Optical Splitter Design Based on Parallel Waveguide Mode Conversion - The new single mode circuit (SMC) architecture is invented for photonic integrated circuits (PIC). This architecture allows using multimode waveguides or structures to construct a single mode operated PIC. The multimode sections used in such SMC based PIC possess strong lateral confinement so that the PIC can have high circuit density and high optical performance at the same time. A parallel mode converter structure is also invented here. Based on this parallel mode converter, a low loss optical splitter can be constructed for high index contrast waveguide system. | 01-12-2012 |
| 20120045162 | Circuit architecture for electro-optic modulation based on free carrier dispersion effect and the waveguide capacitor structures for such modulator circuitry using CMOS or Bi-CMOS process - New circuit architecture for electro-optic modulator based on free-carrier dispersion effect is invented, in which the waveguide capacitor of the modulator is embed in the circuits and physically layout together with transistors, the switching of the modulator occurs in transistors, and as the result, the electro-optical modulation occurs in the waveguide capacitor. The invented modulator is not one physical device, it is actually a circuit. Several circuit design techniques are imported, leading to several new modulator circuits that have very high operation speed and very small power consumption. Several new waveguide capacitor structures are also invented that allow high efficient modulator circuits to be built. | 02-23-2012 |
Bing Li, Towaco, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090253705 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 10-08-2009 |
| 20090258851 | DIARYL SUBSTITUTED ALKANES - The instant invention provides compounds of Formula II which are 5-lipoxygenase activating protein inhibitors. | 10-15-2009 |
| 20100168076 | DIPHENYL SUBSTITUTED ALKANES - The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. | 07-01-2010 |
| 20100190761 | DIPHENYL SUBSTITUTED ALKANES - The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors: formula (I). Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. | 07-29-2010 |
| 20110003815 | DIPHENYL SUBSTITUTED CYCLOALKANES - The present invention provides compounds of Formula I which are FLAP inhibitors useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. | 01-06-2011 |
| 20110028461 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
| 20110028481 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
| 20110190346 | Diphenyl Substituted Alkanes as Flap Inhibitors - The instant invention provides compounds of formula I which are 5-lipoxygenase activating protein inhibitors. | 08-04-2011 |
| 20120108595 | PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS - Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders. | 05-03-2012 |
Bing Li, Singapore SG
| Patent application number | Description | Published |
|---|---|---|
| 20100320763 | METHOD FOR DETERMINING A ROTOR POSITION OF AN ELECTRICAL GENERATOR IN A WIND TURBINE - A method for determining a rotor position of an electrical generator in a wind turbine is described comprising determining a voltage of the electrical generator, determining a rotor position angle estimate based on the voltage of the electrical generator, determining a subsequent rotor position angle estimate through a feedback loop, based on a combination of the voltage of the electrical generator and the rotor position angle estimate. Further, a method to real time track encoder health is described comprising determining the phase angle of a reference voltage, determining the angle difference between the rotor position and the reference voltage, and determining the differentiation of the angle difference. | 12-23-2010 |
| 20100327585 | Control System for an Electrical Generator and Method for Controlling an Electrical Generator - A method for validating and initializing a control system for an electrical generator connected to a power converter in a wind turbine. The method may include generating a first parameter value representing control signal for controlling the stator flux of a stator of the electrical generator, measuring a second parameter value specifying an electrical operational characteristic of the electrical generator, and determining an accuracy level of the control signal based on the first parameter value and the second parameter value, wherein the accuracy level of the control signal has to fall within a predefined threshold for the control system to be validated. | 12-30-2010 |
| 20110109279 | METHOD FOR DETERMINING A ROTOR POSITION OF AN ELECTRICAL GENERATOR IN A WIND TURBINE - A method for determining a rotor position of an electrical generator in a wind turbine is described comprising determining a voltage of the electrical generator, determining a rotor position angle estimate based on the voltage of the electrical generator, determining a subsequent rotor position angle estimate through a feedback loop, based on a combination of the voltage of the electrical generator and the rotor position angle estimate. Further, a method to real time track encoder health is described comprising determining the phase angle of a reference voltage, determining the angle difference between the rotor position and the reference voltage, and determining the differentiation of the angle difference. | 05-12-2011 |
Bing Li, Bejing CN
| Patent application number | Description | Published |
|---|---|---|
| 20100199244 | Formal Verification Of Clock Domain Crossings - Methods and apparatus for performing automated formal clock domain crossing verification on a device are detailed. In various implementations of the invention, a device may be analyzed, wherein the clock domain crossing boundaries are identified. Subsequently, a formal clock domain crossing verification method may be applied to the identified clock domain crossing boundaries, resulting in clock domain crossing assertions being identified. After which the identified assertions may be promoted for post clock domain crossing analysis. With various implementations of the invention, a formal clock domain crossing method is provided, wherein the device components near an identified clock domain crossing are extracted. Assertions may then be synthesized and verified based upon the extracted components. Various implementations of the invention provide for clock domain crossing verification to be performed iteratively, wherein a larger and larger selection of the device is extracted during formal verification. Additionally, various implementations of the present invention provide that the clock domain crossing verification operate on the fly during a device verification procedure. With further implementations, a bit-blasted approach to clock domain crossing verification may be provided during formal verification. | 08-05-2010 |
Bing Li, Foster City, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080248037 | Dr5 Antibodies and Uses Thereof - The application provides antibodies which specifically bind to DR5 receptor. The anti-DR5 antibodies optionally contain CDR sequences identified using phage-display techniques. The DR5 antibodies can be used, for example, in methods where a modulation of the biological activities of Apo-2L and/or Apo-2L receptors is desired, including cancer and immune-related conditions. | 10-09-2008 |
| 20100150908 | Affinity matured CRIg variants - The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3. | 06-17-2010 |
| 20120082666 | ANTIBODY COMPOSITIONS AND METHODS OF USE - The invention provides compositions comprising anti-gH antibodies and anti-Complex I antibodies as well as methods of using the same. | 04-05-2012 |
Bing Li, Owego, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100122943 | Method and System for Identifying and Recognizing Products for Sorting/Sequencing Operations - A method and system is provided for identifying and recognizing products such as mail pieces and, more particularly, a method and system of object recognition based mail piece fingerprinting is provided to be used with sorting and/or sequencing processes. The system for identifying product transported through a machine includes a first system configured to extract one or more unique features from each of a plurality of product and a data storage system configured to store the extracted one or more unique features for each of the plurality of product. The system further includes a second system configured to identify each of the plurality of product by matching the stored extracted one or more unique features with subsequently extracted unique features from each of the plurality of product as the plurality of product continue to be conveyed through a transportation system. | 05-20-2010 |
Bing Li, Shanghai CN
| Patent application number | Description | Published |
|---|---|---|
| 20100054428 | Method, system, and apparatus for overriding a ring back signal - Overriding a ring back signal involves receiving a ring back signal at a communications apparatus from a communication network in response to a user-initiated connection request. The ring back signal is rendered to a user of the communications apparatus, and a user input is received at the communications device to override the ring back signal. An alternate output is rendered to the user in place of the ring back signal. | 03-04-2010 |
Bing Li, Shrewsbury, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090163592 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex - The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements. | 06-25-2009 |
| 20120116090 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex - The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements. | 05-10-2012 |
Bing Li, Worcester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090137804 | Compounds and Compositions as Protein Kinase Inhibitors - The invention relates to compounds of formula (I) | 05-28-2009 |
Bing Li, Shenzhen CN
| Patent application number | Description | Published |
|---|---|---|
| 20080316030 | MOBILE COMMUNICATION DEVICE, ANTI-THEFT METHOD AND SYSTEM - A mobile communication device is provided herein. The mobile communication device includes a touch unit for generating a trigger signal when detecting a touch, a controller for generating an audible alarm in response to the trigger signal, and a transceiver for communicating wirelessly with an anti-theft device. The audible alarm, transmitted to the anti-theft device via the transceiver, is for enabling the anti-theft device to output a first alarm. An anti-theft system and method are also provided. | 12-25-2008 |
Bing Li, Westborough, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080221098 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, Bmx, c-Raf, Csk, Fes, FGFR, Flt3, Ikk, IR, JNK, Lck, Mkk, PKC, PKD, Rsk, SAPK, Syk, Trk, BTK, Src, EGFR, IGF, Mek, Ros and Tie2 kinases. | 09-11-2008 |
Bing Li, Troy, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110236501 | INJECTABLE DUAL DELIVERY ALLOGRAPH BONE/POLYMER COMPOSITE FOR TREATMENT OF OPEN FRACTURES - A biodegradable polyurethane scaffold, comprising at least one polyisocyante, polyisocyanate prepolymer, or both, at least one polyester polyol, at least one catalyst, wherein the density of said scaffold is from about 50 to about 250 kg m-3 and the porosity of the scaffold is greater than about 70 (vol %) and at least 50% of the pores are interconnected with another pore, and wherein the scaffold incorporates at least one biologically active component in powder form. | 09-29-2011 |
Bing Li, Arlington, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120004528 | Implantable Remote Monitoring Sensor - An exemplary implantable sensor includes a housing that generally conforms to a curvature of an anterior chamber of a patient's eye. A sensing device disposed in the housing is configured to detect physiological parameters and transmit a signal representing the physiological parameters. The exemplary sensor may be used to detect physiological parameters such as intraocular pressure, flow velocity of aqueous humor, blood sugar, and blood biochemicals. | 01-05-2012 |
Bing Li, Union City, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120056590 | Very Long Cycling of Lithium Ion Batteries with Lithium Rich Cathode Materials - Lithium ion batteries can be activated and then cycled to exploit a moderate fraction of the discharge cycling capacity such that the discharge capacity and average discharge voltage stay within initial values for thousands of cycles. The superior cycling performance has been achieved at relatively high discharge rates and for practical battery formats. Lithium ion battery performance can also be achieved with superior cycling performance with partially activated batteries such that good discharge capacities can be exploited for many thousands of cycles before the discharge capacity and average discharge voltage drops more than 20% from initial values. The positive electrode active material can be a lithium rich metal oxide. The activation of the battery can comprise phase changes of the active materials. As described herein, the phase changes can be manipulated to exploit a reasonable fraction of the available high capacity of the material while providing outstanding cycling stability. | 03-08-2012 |
| 20120105007 | LITHIUM ION BATTERIES WITH SUPPLEMENTAL LITHIUM - Supplemental lithium can be used to stabilize lithium ion batteries with lithium rich metal oxides as the positive electrode active material. Dramatic improvements in the specific capacity at long cycling have been obtained. The supplemental lithium can be provided with the negative electrode, or alternatively as a sacrificial material that is subsequently driven into the negative electrode active material. The supplemental lithium can be provided to the negative electrode active material prior to assembly of the battery using electrochemical deposition. The positive electrode active materials can comprise a layered-layered structure comprising manganese as well as nickel and/or cobalt. | 05-03-2012 |
| 20120107680 | Lithium Ion Batteries with Supplemental Lithium - Supplemental lithium can be used to stabilize lithium ion batteries with lithium rich metal oxides as the positive electrode active material. Dramatic improvements in the specific capacity at long cycling have been obtained. The supplemental lithium can be provided with the negative electrode, or alternatively as a sacrificial material that is subsequently driven into the negative electrode active material. The supplemental lithium can be provided to the negative electrode active material prior to assembly of the battery using electrochemical deposition. The positive electrode active materials can comprise a layered-layered structure comprising manganese as well as nickel and/or cobalt. | 05-03-2012 |
Bing Li, Northborough, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120064062 | INHIBITORS OF BACTERIAL PLASMINOGEN ACTIVATORS - Organic compounds showing the ability to inhibit bacterial omptin proteases, specifically | 03-15-2012 |
Bing Li, Beijing CN
| Patent application number | Description | Published |
|---|---|---|
| 20120122914 | Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives - The present invention relates to a sustained-release composition containing 2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole or a pharmaceutically acceptable salt thereof as an active ingredient, preparation thereof and the compound. The composition is suitable for oral administration by one time per day, and achieves the peak plasma concentration at 1.0 to 3 hours after oral administration. The composition is suitable for manufacturing a medicament for treatment of cognitive dysfunction syndrome, Alzheimer's disease, Parkinson's disease, Huntington's disease, or senile dementia. | 05-17-2012 |